Table II.
T-cell subset | Group A | Group B | Group C | F | P-value |
---|---|---|---|---|---|
CD3+ (%) | |||||
T1 | 42.98±5.82 | 43.82±6.13 | 45.31±7.33 | 1.67 | 0.19 |
T2 | 56.25±5.91 | 58.83±6.11a | 64.32±6.32a,b | 22.71 | <0.001 |
t | 11.31 | 12.26 | 13.89 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
CD4+ (%) | |||||
T1 | 24.33±4.82 | 25.13±5.12 | 23.92±3.19 | 0.95 | 0.39 |
T2 | 33.77±4.08 | 35.41±5.11 | 39.27±3.91a,b | 20.60 | <0.001 |
t | 10.57 | 10.05 | 21.51 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
CD8+ (%) | |||||
T1 | 33.78±6.78 | 35.86±5.92 | 34.11±6.33 | 1.55 | 0.22 |
T2 | 24.44±5.22 | 26.13±4.91 | 28.11±5.39a | 6.30 | <0.001 |
t | 7.72 | 8.95 | 5.10 | ||
P-value | <0.001 | <0.001 | <0.001 | ||
CD4+/CD8+ | |||||
T1 | 0.72±0.16 | 0.75±0.31 | 0.69±0.11 | 1.09 | 0.37 |
T2 | 1.17±0.21 | 1.38±0.33a | 1.43±0.28a | 12.34 | <0.001 |
t | 12.05 | 9.84 | 17.39 | ||
P-value | <0.001 | <0.001 | <0.001 |
P<0.05 vs. group A
P<0.05 vs. group B.